Registration Now Open for BOS Events 2023!

Bio2Business Ltd is delighted to open registration for BOS Events 2023 which includes: BOS Basel 2023, which will take place on the 4th and 5th of July at Congress Centre Basel; and BOS Manchester 2023, which will take place on the 28th and 29th of November at Manchester Central.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for virtual events during 2023. We look forward to welcoming you and your colleagues to BOS Events 2023! Please contact the Bio2Business team for further details.

Follow us on LinkedIn to see our latest announcements

Featured Company (BOS Manchester 2023)

Logo for Sterling Pharma Solutions
Sterling Pharma Solutions
Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with more than 50 years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling manages...
View profile

Featured Speaker (BOS Basel 2023)

photo of Dr Dr Gerald Gellermann

Deploying Appropriate Spending on Analytical Testing To Avoid Wasting Resources?

Dr Dr Gerald Gellermann, Associate Director, Novartis

ABSTRACT: Molecule and process characterisation are key enables for defining a robust and lean commercial control strategy. Having the risk of an attribute to patient safety and molecule efficacy in focus, a balance needs to be found between success rate of the therapy to make it to the market and phase appropriate investment in analytical method development to gain sufficient molecule and process understanding.
Click here to Read More